Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of TY-51924 in acute myocardial infarction
jRCT2080221705Phase 2
- Sponsor
- TOA EIYO
- Start
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in acute ST-segment elevation myocardial infarction (STEMI) comparing TY-51924 IV with Placebo IV (2 arms).
02
Drugs
TY-51924
03
Conditions
acute ST-segment elevation myocardial infarction (STEMI)
Beyond the preview
Go deeper on jRCT2080221705.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221705.